Helpdesk

Sales contact

Home > Resources > Expert channel > Page 2

Expert channel

Article

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical Officer at Kayentis

Endpoint reliability is a critical factor in the success of clinical trials, particularly those relying on clinician‑reported outcomes. Estelle Haenel, Chief Medical Officer at Kayentis, shares her perspective on why...

Webinar

What if eCOA could elevate your next rare disease trial?

Rare disease

Interview with Prof. Olivier Blin, Professor of Pharmacology, rare disease expert, and Orphan Dev coordinator Despite remarkable progress in rare...

White Paper

Breaking barriers in pediatric clinical trials: perspectives from two expert clinicians

Pediatric

Interview with Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation in Spain, and Vivienne...

Webinar

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

Oncology PRO

Go back ● On-demand The primary aim of Phase 1 oncology clinical trials is to determine the safety of a...

Article

Expanding investor confidence: The strategic value of Patient Reported Outcomes (PROs) in biotech fundraising

biotech fundraising PRO

For biotech companies engaged in the clinical development of a therapeutic innovation, securing investor trust is as critical as demonstrating...

Article

Leveraging the potential of Patient Reported Outcome (PRO) data to accelerate therapeutic innovation market access

biotech market access PRO

Patients Reported Outcome (PRO) data provide information on patient health that is obtained directly from the patient.PRO measures serve to...

Webinar

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies

biotech PRO

In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

Article

If Patients Want A Better Quality Of Life, Why Isn’t That A Focus For Pharma?

Oncology Patient engagement

A conversation with Frédéric Fiteni, Ph.D., medical oncologist and oncology PRO specialist, University Hospital of Nîmes, and, member of Kayentis Scientific...

Podcast

Bringing the patient’s voice to clinical trials

Patient’s voice Patients insights

In this interview, engagement advocate and cystic fibrosis patient Thomas Smith shares his experiences of being the patient voice in...

Podcast

Rethinking pediatric clinical trials: guidelines from pediatric experts

Pediatric Sites perspectives

In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Podcast

Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts

Pediatric Sites perspectives

In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Podcast

How DCTs Can Help Pediatric Clinical Research – Insights From Site Experts

Pediatric Sites perspectives

In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Podcast

How to avoid common pitfalls when implementing DCT solutions in your clinical trials?

Decentralized trials

In this episode, Ally Hochman, Clinical Operations Project Manager at Kayentis, offers valuable insights into enhancing technology adoption, establishing enduring...

Podcast

Decentralized trials: keys to achieving success

Decentralized trials

What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?...

Podcast

Exploring The Specific Challenges Of Pediatric Clinical Trials – Insights From Site Experts

Pediatric Sites perspectives

In this first episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Podcast

DCT and health disparities: Insights from a patient advocate

Decentralized trials Patients insights

Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor,...

White Paper

Do we have the right understanding of how patients perceive digital clinical trials?

Patients insights

Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...

Subscribe to our newsletter

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical...

Kayentis and RWS join forces to improve data confidence in...

What if eCOA could elevate your next rare disease trial?

Elevating rare disease clinical trials through eCOA – From patient...

Overcoming rare disease trial challenges: the strategic impact of eCOA

Kayentis and Perceptive eClinical partner to tackle increasing digital system...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.